BeyondSpring (BYSI) Stock Analysis
NASDAQHealthcareBiotechnology
What BeyondSpring does
BeyondSpring Inc. is a clinical-stage biopharmaceutical company focused on developing novel cancer treatments. Its flagship product is Plinabulin, a selective immune-modulating and microtubule-binding agent. Plinabulin has successfully advanced through Phase III clinical trials for two distinct applications: the prevention of chemotherapy-induced neutropenia, and the treatment of advanced non-small cell lung cancer. The company is also exploring Plinabulin's efficacy in combination with various immuno-oncology drugs; specifically, alongside nivolumab (a PD-1 antibody) for NSCLC, and with nivolumab and ipilimumab (a CTLA-4 antibody) for small cell lung cancer (SCLC). Furthermore, it is being investigated in conjunction with PD-1 or PD-L1 antibodies and radiation to address a range of cancers. Beyond its lead asset, BeyondSpring's pipeline includes three preclinical-stage small molecule immune agents and a proprietary drug development platform. The company, founded in 2010, maintains its headquarters in New York, New York.
Key metrics
ETFs linked to BYSI
Broad-market and Healthcare sector ETFs an investor holding BeyondSpring is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how BYSI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze BYSI in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for BeyondSpring?
- BeyondSpring trades under the ticker BYSI on NASDAQ.
- Which exchange is BYSI listed on?
- BYSI is listed on NASDAQ.
- What sector does BeyondSpring operate in?
- BeyondSpring is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze BYSI in a portfolio?
- PortView shows BYSI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.